Table 8.
Relevance of barriers to PrEP use.
n | M (SD) | Min-Max | ||
---|---|---|---|---|
Worries about getting infected with other STIs | 111 | 5.56 | (2.73) | 0-10 |
The monthly costs for the PrEP medication | 109 | 5.33 | (2.61) | 0-10 |
Lack of information about PrEP in the native language of the client | 110 | 5.10 | (3.33) | 0-10 |
The costs for the laboratory investigations | 109 | 4.80 | (3.00) | 0-10 |
Worries about mild or temporary side effects | 109 | 4.64 | (2.43) | 0-10 |
Time required for regular visits to the doctor | 111 | 4.26 | (2.81) | 0-10 |
Worries about severe or permanent side effects | 111 | 4.21 | (2.59) | 0-10 |
Lack of information about PrEP in client-friendly language | 110 | 4.17 | (2.88) | 0-10 |
Difficulties finding a doctor who prescribes PrEP | 112 | 4.13 | (3.64) | 0-10 |
Assessment of the own risk of getting infected with HIV as too low to take PrEP | 110 | 4.08 | (2.70) | 0-10 |
Worries about stigmatization in the peer group | 107 | 3.33 | (2.67) | 0-10 |
Cultural barriers | 110 | 2.79 | (2.51) | 0-10 |
M, mean; Max, maximum; Min, minimum; SD, standard deviation.